Market Research Logo

Aptose Biosciences Inc (APTO) - Financial and Strategic SWOT Analysis Review

Aptose Biosciences Inc (APTO) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Aptose Biosciences Inc (Aptose) is a clinical-stage biotechnology company which focuses on diagnostics, therapies and treatment for patients with life-threatening cancers. The company advances in new therapeutics which focuses on cellular targets of cancer research coupled with companion diagnostics to identify patient with cancer. Its small molecule cancer therapeutics pipeline includes products which are designed to provide single agent efficacy and efficacy of other anti-cancer therapies and regimens without overlapping toxicities. The company’s product portfolio comprises of CG’806, is a non-covalent small molecule therapeutic agent. Aptose is headquartered in Toronto, Ontario, Canada.

Aptose Biosciences Inc Key Recent Developments

Aug 07,2018: Aptose reports results for the second quarter ended june 30, 2018
May 10,2018: Aptose Reports Results for the First Quarter Ended March 31, 2018
Apr 25,2018: Aptose Names Caroline M. Loewy As Board Director
Mar 27,2018: Aptose Reports Results for the Fourth Quarter and Year Ended December 31, 2017
Feb 07,2018: Aptose Biosciences Files New Preliminary Base Shelf Prospectus to Replace Expired Base Prospectus

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Aptose Biosciences Inc - Key Facts
Aptose Biosciences Inc - Key Employees
Aptose Biosciences Inc - Key Employee Biographies
Aptose Biosciences Inc - Major Products and Services
Aptose Biosciences Inc - History
Aptose Biosciences Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Aptose Biosciences Inc - Business Description
Aptose Biosciences Inc - Corporate Strategy
Aptose Biosciences Inc - SWOT Analysis
SWOT Analysis - Overview
Aptose Biosciences Inc - Strengths
Aptose Biosciences Inc - Weaknesses
Aptose Biosciences Inc - Opportunities
Aptose Biosciences Inc - Threats
Aptose Biosciences Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Aptose Biosciences Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 10, 2018: Aptose Reports Results for the First Quarter Ended March 31, 2018
Mar 27, 2018: Aptose Reports Results for the Fourth Quarter and Year Ended December 31, 2017
Feb 07, 2018: Aptose Biosciences Files New Preliminary Base Shelf Prospectus to Replace Expired Base Prospectus
Nov 14, 2017: Aptose Reports Results for the Third Quarter Ended September 30, 2017
Aug 08, 2017: Aptose Reports Results for the Second Quarter Ended June 30, 2017
May 11, 2017: Aptose Reports Results for the First Quarter Ended March 31, 2017
Mar 28, 2017: Aptose Reports Fourth Quarter and Year End 2016 Results
Mar 27, 2017: Aptose Announces Planned Departure of Chief Business Officer
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Aptose Biosciences Inc, Key Facts
Aptose Biosciences Inc, Key Employees
Aptose Biosciences Inc, Key Employee Biographies
Aptose Biosciences Inc, Major Products and Services
Aptose Biosciences Inc, History
Aptose Biosciences Inc, Other Locations
Aptose Biosciences Inc, Key Competitors
Aptose Biosciences Inc, Ratios based on current share price
Aptose Biosciences Inc, Annual Ratios
Aptose Biosciences Inc, Annual Ratios (Cont...1)
Aptose Biosciences Inc, Interim Ratios
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Aptose Biosciences Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Aptose Biosciences Inc, Performance Chart (2013 - 2017)
Aptose Biosciences Inc, Ratio Charts
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report